Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor 1 gene in breast cancer cells

Molecular Endocrinology

Volumn 19, Issue 6, 2005, Pages 1584-1592

  Laganière, Josée ^a,b   Deblois, Geneviève ^a   Giguère, Vincent ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN; RECEPTOR PROTEIN; RETINOIC ACID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTION FACTOR SP1;

ARTICLE; CANCER CELL CULTURE; CHROMATIN; CONTROLLED STUDY; DNA FLANKING REGION; ESTROGEN RESPONSIVE ELEMENT; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE LOCUS; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; INTRON; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; UPREGULATION;

ACETYLTRANSFERASES; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; CLONING, MOLECULAR; CONSERVED SEQUENCE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENOME; HISTONE ACETYLTRANSFERASES; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 22344438888     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2005-0040     Document Type: Article

References (52)

1. Green S, Walter P, Kumar V, Krust A, Bornet JM, Argos P, Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-erbA. Nature 320:134-139
2. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM 1985 Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635-641
3. Giguère V, Hollenberg SH, Rosenfeld MG, Evans RM 1986 Functional domains of the human glucocorticoid receptor. Cell 46:645-652
4. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P 1987 Functional domains of the human estrogen receptor. Cell 51:941-951
5. 3 receptors. Cell 65:1255-1266
6. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
7. Gamble MJ, Freedman LP 2002 A coactivator code for transcription. Trends Biochem Sci 27:165-167
8. Glass CK, Rosenfeld MG 2000 The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141
9. Yamamoto KR 1985 Steroid receptor regulated transcription of specific gene networks. Annu Rev Genet 19:209-252
10. Herrlich P 2001 Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20:2465-2475
11. Pfahl M 1993 Nuclear receptor/AP-1 interaction. Endocr Rev 14:651-658
12. Safe S, Kim K 2004 Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acid Res Mol Biol 77:1-36
13. Lippman M, Bolan G, Huff K 1976 The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36:4595-4601
14. O'Lone R, Frith MC, Karlsson EK, Hansen U 2004 Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18:1859-1875
15. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, Hayashi S 2002 Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29:175-192
16. Seth P, Krop I, Porter D, Polyak K 2002 Novel estrogen and tamoxifen induced genes identified by SAGE (serial analysis of gene expression). Oncogene 21:836-843
17. Soulez M, Parker MG 2001 Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol 27:259-274
18. Lobenhofer EK, Bennett L, Cable PL, Li L, Bushel PR, Afshari CA 2002 Regulation of DNA replication fork genes by 17β-estradiol. Mol Endocrinol 16:1215-1229
19. Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M 2004 Molecular identification of ERa-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes. J Cell Physiol 200:440-450
20. Coser KR, Chesnes J, Hur J, Ray S, Isselbacher KJ, Shioda T 2003 Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray. Proc Natl Acad Sci USA 100:13994-13999
21. Wang DY, Fulthorpe R, Liss SN, Edwards EA 2004 Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Mol Endocrinol 18:402-411
22. Cunliffe HE, Ringner M, Bilke S, Walker RL, Cheung JM, Chen Y, Meltzer PS 2003 The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. Cancer Res 63:7158-7166
23. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574
24. Charpentier AH, Bednarek AK, Daniel RL, Hawkins KA, Laflin KJ, Gaddis S, MacLeod MC, Aldaz CM 2000 Effects of estrogen on global gene expression: identifica-tion of novel targets of estrogen action. Cancer Res 60:5977-5983
25. Lin CY, Strom A, Vega VB, Kong SL, Yeo AL, Thomsen JS, Chan WC, Doray B, Bangarusamy DK, Ramasamy A, Vergara LA, Tang S, Chong A, Bajic VB, Miller LD, Gustafsson JA, Liu ET 2004 Discovery of estrogen receptor α target genes and response elements in breast tumor cells. Genome Biol 5:R66. 1-R66.18
26. Laganière J, Deblois G, Giguère V 2003 Nuclear receptor target gene discovery using high throughput chromatin immunoprecipitation. In: Russell DW, Mangelsdorf DJ, eds. Methods in enzymology. San Diego: Academic Press; 339-350
27. Berry M, Nunez A-M, Chambon P 1989 Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86:1218-1222
28. Kang HY, Yeh S, Fujimoto N, Chang C 1999 Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J Biol Chem 274:8570-8576
29. Hermanson O, Glass CK, Rosenfeld MG 2002 Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 13:55-60
30. Giguère V 1994 Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 15:61-79
31. Farias EF, Arapshian A, Bleiweiss IJ, Waxman S, Zelent A, Mira YLR 2002 Retinoic acid receptor a2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells. Cell Growth Differ 13:335-341
32. Sun G, Porter W, Safe S 1998 Estrogen-induced retinoic acid receptor α1 gene expression: role of estrogen receptor-Sp1 complex. Mol Endocrinol 12:882-890
33. Zou A, Marschke KB, Arnold KE, Berger EM, Fitzgerald P, Mais DE, Allegretto EA 1999 Estrogen receptor β activates the human retinoic acid receptor α-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen. Mol Endocrinol 13:418-430
34. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA 2004 Control of pancreas and liver gene expression by HNF transcription factors. Science 303:1378-1381
35. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, Wheeler R, Wong B, Drenkow J, Yamanaka M, Patel S, Brubaker S, Tammana H, Helt G, Struhl K, Gingeras TR 2004 Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116:499-509
36. Zhu WY, Jones CS, Kiss A, Matsukuma K, Amin S, De Luca LM 1997 Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells. Exp Cell Res 234:293-299
37. 3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death. Cancer Res 60:2040-2048
38. Leroy P, Krust A, Zelent A, Mendelsohn C, Garnier JM, Kastner P, Dierich A, Chambon P 1991 Multiple isoforms of the mouse retinoic acid receptor α are generated by alternative splicing and differential induction by retinoic acid. EMBO J 10:59-69
39. van der Leede BJ, Folkers GE, van den Brink CE, van der Saag PT, van der Burg B 1995 Retinoic acid receptor a1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol Cell Endocrinol 109:77-86
40. Rishi AK, Shao ZM, Baumann RG, Li XS, Sheikh MS, Kimura S, Bashirelahi N, Fontana JA 1995 Estradiol regulation of the human retinoic acid receptor α gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res 55:4999-5006
41. Fontana JA, Nervi C, Shao ZM, Jetten AM 1992 Retinoid antagonism of estrogen-responsive transforming growth factor α and pS2 gene expression in breast carcinoma cells. Cancer Res 52:3938-3945
42. 3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54:1458-1464
43. Muller P, Kietz S, Gustafsson JA, Strom A 2002 The anti-estrogenic effect of all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expression. J Biol Chem 277:28376-28379
44. Rousseau C, Pettersson F, Couture MC, Paquin A, Galipeau J, Mader S, Miller Jr WH 2003 The N-terminal of the estrogen receptor (ERα) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells. J Steroid Biochem Mol Biol 86:1-14
45. Eng FCS, Barsalou A, Akutsu N, Mercier I, Zechel C, Mader S, White JH 1998 Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain. J Biol Chem 273:28371-28377
46. L'Horset F, Dauvois S, Heery DM, Cavaillès V, Parker MG 1996 RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol 16:6029-6036
47. Chuang FM, West BL, Baxter JD, Schaufele F 1997 Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy. Mol Endocrinol 11:1332-1341
48. White KA, Yore MM, Deng D, Spinella MJ 2005 Limiting effects of RIP140 in estrogen signaling: potential mediation of anti-estrogenic effects of retinoic acid. J Biol Chem 280:7829-7835
49. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F 2003 Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763
50. Metivier R, Penot G, Carmouche RP, Hubner MR, Reid G, Denger S, Manu D, Brand H, Kos M, Benes V, Gannon F 2004 Transcriptional complexes engaged by apo-estrogen receptor-a isoforms have divergent outcomes. EMBO J 23:3653-3666
51. Bourdeau V, Deschenes J, Metivier R, Nagai Y, Nguyen D, Bretschneider N, Gannon F, White JH, Mader S 2004 Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol Endocrinol 18:1411-1427
52. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguère V 1997 Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β. Mol Endocrinol 11:353-365